News

Alveolar macrophage cell surface receptor TREM2 promotes lung fibrosis, study shows
Lung macrophages play a pivotal role in diseases like idiopathic pulmonary fibrosis. Two types of macrophages—the white blood ...
Mucus v. Phlegm: What’s The Difference?
Regular mucus tends to be thin and slippery, and it is generally a constant presence on a day-to-day basis. Meanwhile, phlegm ...
Stocktwits on MSN3d
Vertex Pharma’s New Cystic Fibrosis Drug Granted Approval By EU
Vertex Pharmaceuticals (VRTX) on Tuesday announced that the European Commission has granted approval for Alyftrek for the ...
EU approves Vertex's next-generation cystic fibrosis drug
Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...
Agence France-Presse3d
Vertex Announces European Commission Approval of ALYFTREK®, a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK ® (deutivacaftor/tezacaftor/vanzacaftor) for the treatment of people with cystic ...
BMJ6d
Recent advances in the management of cystic fibrosis
Background Cystic fibrosis (CF) affects over 8000 people in the UK and an estimated 100 000 globally. Prognosis has improved greatly over the last few decades, but patients still have a reduced life ...
Now To Love6d
Ben Prince-Saxon’s fight against cystic fibrosis
Ben is running 12 marathons in 12 months to raise awareness for cystic fibrosis, a condition he's battled since childhood.